Proteomics and its role in drug discovery and development

被引：0
|
作者：
Nishimura, T [1 ]
机构：
[1] Tokyo Med Univ, Clin Proteom Ctr, Shinjuku Ku, Tokyo 1630203, Japan
来源：
SEIKAGAKU | 2004年 / 76卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1344 / 1352
页数：9
相关论文
共 50 条
  • [31] Proteomics and drug discovery in cancer
    Dias, Matheus H.
    Kitano, Eduardo S.
    Zelanis, Andre
    Iwai, Leo K.
    DRUG DISCOVERY TODAY, 2016, 21 (02) : 264 - 277
  • [32] Structural proteomics and drug discovery
    Kaldor, SW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U5 - U5
  • [33] Drug Discovery and Development: the Role of NMR
    Everett, Jeremy R.
    EMAGRES, 2015, 4 (01): : 137 - 149
  • [34] Role of pharmacogenomics in drug discovery and development
    Surendiran, A.
    Pradhan, S. C.
    Adithan, C.
    INDIAN JOURNAL OF PHARMACOLOGY, 2008, 40 (04) : 137 - 143
  • [35] The role of academia in drug discovery and development
    Yamada, Yasuhide
    Kim, Tae Won
    CANCER SCIENCE, 2018, 109 : 42 - 42
  • [36] The Role of Radiopharmaceuticals in Drug Discovery and Development
    Kairemo, Kalevi
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (09) : 926 - 927
  • [37] Role of toxicology in drug discovery and development
    Goldstein, RS
    IDEA TO PRODUCT: THE PROCESS, 1996, : 47 - 48
  • [38] THE ROLE OF REDUCTASES IN DRUG DISCOVERY AND DEVELOPMENT
    Di, Li
    DRUG METABOLISM AND PHARMACOKINETICS, 2019, 34 (01) : S62 - S62
  • [39] The role of emerging genomics and proteomics technologies in cancer drug target discovery
    Onyango, P
    CURRENT CANCER DRUG TARGETS, 2004, 4 (02) : 111 - 124
  • [40] The emerging role of mass spectrometry-based proteomics in drug discovery
    Meissner, Felix
    Geddes-McAlister, Jennifer
    Mann, Matthias
    Bantscheff, Marcus
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (09) : 637 - 654
12345